Thus, the anti-inflammatory gene expression in the presence of high concentrations of C5a, emphasizes the therapeutic advantage of the inhibition of C5aR1, without interfering with other anti-inflammatory signaling as an optimal efficacious strategy for modulating the consequences of C5a generation in AD and perhaps AD-related dementias. The gene discussed is C5AR1; the disease is Alzheimer disease.